{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T11:05:35Z","timestamp":1779102335736,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.jsat.2011.02.002","type":"journal-article","created":{"date-parts":[[2011,4,3]],"date-time":"2011-04-03T15:56:00Z","timestamp":1301846160000},"page":"88-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Factors associated with Medicaid patients' access to buprenorphine treatment"],"prefix":"10.1016","volume":"41","author":[{"given":"Jeffrey D.","family":"Baxter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin E.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihail","family":"Samnaliev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary Y.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lobat","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jsat.2011.02.002_bb0005","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1023\/B:APIH.0000003017.78877.56","article-title":"Mental and substance use disorders among Medicaid recipients: Prevalence estimates from two national surveys","volume":"31","author":"Adelmann","year":"2003","journal-title":"Administration & Policy in Mental Health"},{"key":"10.1016\/j.jsat.2011.02.002_bb0010","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1086\/508181","article-title":"The potential role of buprenorphine in the treatment of opioid dependence in HIV-infected individuals and in HIV infection prevention","volume":"4","author":"Altice","year":"2006","journal-title":"Clinical Infectious Diseases, 43 Suppl"},{"issue":"1","key":"10.1016\/j.jsat.2011.02.002_bb0015","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2307\/3349613","article-title":"Societal and individual determinants of medical care utilization in the United States","volume":"51","author":"Andersen","year":"1973","journal-title":"Milbank Memorial Fund Quarterly - Health & Society"},{"issue":"1","key":"10.1016\/j.jsat.2011.02.002_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2307\/2137284","article-title":"Revisiting the behavioral model and access to medical care: Does it matter?","volume":"36","author":"Andersen","year":"1995","journal-title":"Journal of Health & Social Behavior"},{"issue":"1\u20133","key":"10.1016\/j.jsat.2011.02.002_bb0025","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.drugalcdep.2007.11.018","article-title":"Opioid use disorder in the United States: Insurance status and treatment access","volume":"94","author":"Becker","year":"2008","journal-title":"Drug & Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.jsat.2011.02.002_bb0030","first-page":"791","article-title":"Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs","volume":"34","author":"Broome","year":"1999","journal-title":"Health Services Research"},{"issue":"1","key":"10.1016\/j.jsat.2011.02.002_bb0035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archpsyc.1997.01830130077015","article-title":"Psychiatric and substance use comorbidity among treatment-seeking opioid abusers","volume":"54","author":"Brooner","year":"1997","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jsat.2011.02.002_bb0040","series-title":"Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04-3939","author":"Center for Substance Abuse Treatment","year":"2004"},{"key":"10.1016\/j.jsat.2011.02.002_bb0045","series-title":"Medication Assisted Treatment for Opioid Addiction in Opioid Treatment Programs. Treatment Improvement Protocol (TIP) Series 43. DHHS Publication No. (SMA) 05-4048","author":"Center for Substance Abuse Treatment","year":"2005"},{"issue":"2","key":"10.1016\/j.jsat.2011.02.002_bb0050","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.drugalcdep.2005.05.009","article-title":"Major increases in opioid analgesic abuse in the United States: Concerns and strategies","volume":"81","author":"Compton","year":"2006","journal-title":"Drug & Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.jsat.2011.02.002_bb0055","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4088\/JCP.v67n0211","article-title":"Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"67","author":"Conway","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1016\/j.jsat.2011.02.002_bb0060","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/10550490050173217","article-title":"The effect of stimulant and sedative use on treatment outcome of patients admitted to methadone maintenance treatment","volume":"9","author":"DeMaria","year":"2000","journal-title":"American Journal on Addictions"},{"key":"10.1016\/j.jsat.2011.02.002_bb0065","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1747-597X-3-17","article-title":"State policy influence on the early diffusion of buprenorphine in community treatment programs","volume":"3","author":"Ducharme","year":"2008","journal-title":"Substance Abuse Treatment, Prevention, & Policy"},{"issue":"2","key":"10.1016\/j.jsat.2011.02.002_bb0070","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/ADM.0b013e3180473c11","article-title":"The first three years of buprenorphine in the United States: Experience to date and future directions","volume":"1","author":"Fiellin","year":"2007","journal-title":"Journal of Addiction Medicine"},{"issue":"2 Suppl","key":"10.1016\/j.jsat.2011.02.002_bb0075","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0376-8716(03)00055-3","article-title":"From morphine clinics to buprenorphine: Regulating opioid agonist treatment of addiction in the United States","volume":"70","author":"Jaffe","year":"2003","journal-title":"Drug & Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.jsat.2011.02.002_bb0080","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.drugalcdep.2003.11.014","article-title":"Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program","volume":"74","author":"Kidorf","year":"2004","journal-title":"Drug & Alcohol Dependence"},{"issue":"19","key":"10.1016\/j.jsat.2011.02.002_bb0085","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1001\/jama.2008.648","article-title":"Methadone maintenance 4 decades later: Thousands of lives saved but still controversial","volume":"300","author":"Kleber","year":"2008","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.jsat.2011.02.002_bb0090","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.3109\/10826089909039442","article-title":"Active heroin injectors' perceptions and use of methadone maintenance treatment: Cynical performance or self-prescribed risk reduction?","volume":"34","author":"Koester","year":"1999","journal-title":"Substance Use & Misuse"},{"issue":"3","key":"10.1016\/j.jsat.2011.02.002_bb0095","first-page":"29","article-title":"Improving health-based payment for Medicaid beneficiaries: CDPS (Chronic Illness and Disability Payment System)","volume":"21","author":"Kronick","year":"2000","journal-title":"Health Care Financing Review"},{"issue":"7","key":"10.1016\/j.jsat.2011.02.002_bb0100","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/jama.294.7.784","article-title":"Office-based treatment for opioid addiction achieving goals","volume":"294","author":"Kuehn","year":"2005","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jsat.2011.02.002_bb0105","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1360-0443.1998.931516.x","article-title":"Pre- and in-treatment predictors of retention in methadone treatment using survival analysis","volume":"93","author":"Magura","year":"1998","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.jsat.2011.02.002_bb0110","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0376-8716(00)00162-9","article-title":"The economic costs of heroin addiction in the United States","volume":"61","author":"Mark","year":"2001","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.jsat.2011.02.002_bb0115","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1360-0443.1998.9345157.x","article-title":"The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: A meta-analysis","volume":"93","author":"Marsch","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2011.02.002_bb0120","first-page":"1","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","author":"Mattick","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jsat.2011.02.002_bb0125","first-page":"1","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1016\/j.jsat.2011.02.002_bb0130","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.addbeh.2008.06.005","article-title":"Trends in prescription drug abuse and dependence, co-occurrence with other substance use disorders, and treatment utilization: Results from two national surveys","volume":"33","author":"McCabe","year":"2008","journal-title":"Addictive Behaviors"},{"issue":"9","key":"10.1016\/j.jsat.2011.02.002_bb0135","first-page":"1049","article-title":"Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: An 18-month prospective follow-up","volume":"6","author":"Metzger","year":"1993","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"22","key":"10.1016\/j.jsat.2011.02.002_bb0140","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1001\/jama.280.22.1936","article-title":"Effective medical treatment of opiate addiction","volume":"280","author":"National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction","year":"1998","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.jsat.2011.02.002_bb0145","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMp1011512","article-title":"A flood of opioids, a rising tide of deaths","volume":"363","author":"Okie","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1016\/j.jsat.2011.02.002_bb0150","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/pds.1276","article-title":"Increasing deaths from opioid analgesics in the United States","volume":"15","author":"Paulozzi","year":"2006","journal-title":"Pharmacoepidemiology & Drug Safety"},{"issue":"10","key":"10.1016\/j.jsat.2011.02.002_bb0155","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/pds.1626","article-title":"Recent changes in drug poisoning mortality in the United States by urban-rural status and by drug type","volume":"17","author":"Paulozzi","year":"2008","journal-title":"Pharmacoepidemiology & Drug Safety"},{"issue":"1","key":"10.1016\/j.jsat.2011.02.002_bb0160","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2105\/AJPH.88.1.34","article-title":"Retention, HIV risk, and illicit drug use during treatment: methadone dose and visit frequency","volume":"88","author":"Rhoades","year":"1998","journal-title":"American Journal of Public Health"},{"issue":"11","key":"10.1016\/j.jsat.2011.02.002_bb0165","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/j.1360-0443.2008.02323.x","article-title":"The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: Evidence from the MANIF2000 cohort study","volume":"103","author":"Roux","year":"2008","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.jsat.2011.02.002_bb0170","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/10550490050172218","article-title":"Importance of identifying cocaine and alcohol dependent methadone clients","volume":"9","author":"Rowan-Szal","year":"2000","journal-title":"American Journal on Addictions"},{"key":"10.1016\/j.jsat.2011.02.002_bb0175","series-title":"Results from the 2008 National Survey on Drug Use and Health: National Findings","author":"Substance Abuse and Mental Health Services Administration","year":"2009"},{"key":"10.1016\/j.jsat.2011.02.002_bb0180","series-title":"The SAMHSA Evaluation of the Impact of the DATA Waiver Program: Summary Report (FINAL): Conducted under Task Order 277-00-6111 for SAMHSA by Westat","author":"Substance Abuse and Mental Health Services Administration (SAMHSA)","year":"2006"},{"key":"10.1016\/j.jsat.2011.02.002_bb0185","series-title":"Results from the 2006 National Survey on Drug Use and Health: National Findings","author":"Substance Abuse and Mental Health Services Administration (SAMHSA)","year":"2007"},{"issue":"Suppl 4","key":"10.1016\/j.jsat.2011.02.002_bb0190","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1086\/508183","article-title":"Initial strategies for integrating buprenorphine into HIV care settings in the United States","volume":"43","author":"Sullivan","year":"2006","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1016\/j.jsat.2011.02.002_bb0195","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.drugalcdep.2004.12.008","article-title":"The practice of office-based buprenorphine treatment of opioid dependence: Is it associated with new patients entering into treatment?","volume":"79","author":"Sullivan","year":"2005","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.jsat.2011.02.002_bb0200","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1360-0443.2004.00963.x","article-title":"Decreasing international HIV transmission: The role of expanding access to opioid agonist therapies for injection drug users","volume":"100","author":"Sullivan","year":"2005","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.jsat.2011.02.002_bb0205","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jsat.2007.08.004","article-title":"Buprenorphine\/Naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors","volume":"35","author":"Sullivan","year":"2008","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.jsat.2011.02.002_bb0210","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1521-0391.2009.00003.x","article-title":"The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine\/naloxone for the treatment of opioid dependence","volume":"19","author":"Sullivan","year":"2010","journal-title":"American Journal on Addictions"},{"issue":"15","key":"10.1016\/j.jsat.2011.02.002_bb0215","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1001\/archinte.165.15.1769","article-title":"Barriers and facilitators to primary care or human immunodeficiency virus clinics providing methadone or buprenorphine for the management of opioid dependence","volume":"165","author":"Turner","year":"2005","journal-title":"Archives of Internal Medicine"},{"issue":"6","key":"10.1016\/j.jsat.2011.02.002_bb0220","first-page":"469","article-title":"Direct costs of opioid abuse in an insured population in the United States","volume":"11","author":"White","year":"2005","journal-title":"J Manag Care Pharm"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547211000298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547211000298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:35:40Z","timestamp":1760038540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547211000298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0740547211000298"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2011.02.002","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors associated with Medicaid patients' access to buprenorphine treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2011.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}